ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.
ARCS has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
ARCS's investors include Mitsubishi UFJ Capital, Mizuho Capital, Deepcore, Money Forward Venture Partners, JAFCO.
ARCS is headquartered in Tokyo, Japan.
ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.
ARCS is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ARCS — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/arcs. Accessed August 14, 2026.
VCBacked. (2025). ARCS — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/arcs
{{cite web |title=ARCS — Funding & Investors |url=https://www.vcbacked.co/company/arcs |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated